Seed Co., Ltd. (JP:7743)
:7743
Top Page
Seed Co., Ltd.
(7743)
Select Model
Select Model
Rating:58Neutral
Price Target:
¥646.00
▲(12.35% Upside)
Action:ReiteratedDate:03/24/26
The score is held back primarily by weaker fundamentals—especially negative TTM free cash flow and meaningful leverage—despite steady revenue growth and solid gross margins. Technicals are a positive, with price trending above major moving averages and supportive momentum indicators. Valuation is a headwind due to the high P/E, only partly cushioned by a ~2.4% dividend yield.
Positive Factors
Revenue growth & gross margin
Sustained revenue growth with a high ~44.8% gross margin indicates durable product economics in contact lenses. Healthy gross margin supports reinvestment, resiliency to input-cost swings, and long-term cash generation potential across core product lines over the next several quarters.
Negative Factors
Meaningful leverage
Debt-to-equity near 1.4 represents material leverage that constrains strategic flexibility. Higher leverage raises interest burden and reduces the firm's ability to fund growth or absorb revenue/margin shocks, increasing refinancing and liquidity risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth & gross margin
Sustained revenue growth with a high ~44.8% gross margin indicates durable product economics in contact lenses. Healthy gross margin supports reinvestment, resiliency to input-cost swings, and long-term cash generation potential across core product lines over the next several quarters.
Read all positive factors
Seed Co., Ltd. (7743) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥18.25B
Dividend Yield2.65%
Average Volume (3M)68.49K
Price to Earnings (P/E)58.3
Beta (1Y)0.59
Revenue Growth0.81%
EPS Growth-26.76%
CountryJP
Employees962
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)2.47
Shares Outstanding30,265,923
10 Day Avg. Volume58,390
30 Day Avg. Volume68,493
Financial Highlights & Ratios
PEG Ratio-0.25
Price to Book (P/B)0.82
Price to Sales (P/S)0.44
P/FCF Ratio-8.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)46.9
Revenue Forecast (FY)¥39.70B
Seed Co., Ltd. Business Overview & Revenue Model
Company Description
SEED Co.,Ltd. manufactures and supplies contact lenses, care products, spectacle frames, and other eye care products in Japan and internationally. The company offers SEED 1dayPure moisture daily disposable, SEED 1dayPure moisture multistage, SEED ...
How the Company Makes Money
null...
Seed Co., Ltd. Financial Statement Overview
Summary
Income Statement
68
Positive
Balance Sheet
54
Neutral
Cash Flow
41
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.57B | 33.23B | 32.40B | 30.59B | 28.84B | 28.62B |
| Gross Profit | 15.14B | 14.63B | 14.18B | 11.62B | 12.01B | 12.41B |
| EBITDA | 5.18B | 5.05B | 5.12B | 2.83B | 4.45B | 4.55B |
| Net Income | 1.17B | 1.09B | 1.96B | -316.09M | 1.15B | 1.13B |
Balance Sheet | ||||||
| Total Assets | 53.02B | 51.76B | 49.57B | 40.01B | 41.79B | 41.26B |
| Cash, Cash Equivalents and Short-Term Investments | 5.17B | 7.12B | 9.89B | 4.94B | 3.88B | 3.96B |
| Total Debt | 25.64B | 26.26B | 24.18B | 20.89B | 22.04B | 22.86B |
| Total Liabilities | 34.13B | 33.38B | 31.92B | 27.87B | 29.25B | 29.61B |
| Stockholders Equity | 18.58B | 18.06B | 17.36B | 11.86B | 12.26B | 11.49B |
Cash Flow | ||||||
| Free Cash Flow | -206.19M | -1.70B | 2.19B | 2.79B | 2.15B | 1.52B |
| Operating Cash Flow | 2.43B | 2.98B | 6.02B | 3.35B | 3.27B | 3.69B |
| Investing Cash Flow | -3.19B | -4.57B | -3.76B | -440.73M | -881.61M | -1.66B |
| Financing Cash Flow | -2.46B | -1.13B | 2.64B | -1.82B | -2.42B | -1.73B |
Seed Co., Ltd. Technical Analysis
Positive
575.00
Price Trends
563.07
Positive
562.87
Positive
533.60
Positive
Market Momentum
16.94
Negative
58.51
Neutral
68.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7743, the sentiment is Positive. The current price of 575 is below the 20-day moving average (MA) of 600.77, above the 50-day MA of 563.07, and above the 200-day MA of 533.60, indicating a bullish trend. The MACD of 16.94 indicates Negative momentum. The RSI at 58.51 is Neutral, neither overbought nor oversold. The STOCH value of 68.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7743.
Seed Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥50.99B | 10.70 | ― | 3.22% | 12.92% | 29.48% | |
75 Outperform | ¥214.53B | 15.29 | 9.53% | 2.19% | 8.90% | -3.71% | |
74 Outperform | ¥133.52B | 9.26 | 7.81% | 1.78% | 3.17% | 7.07% | |
71 Outperform | ¥151.03B | 18.72 | ― | 2.73% | 5.10% | -26.13% | |
65 Neutral | ¥125.34B | 23.93 | 27.95% | 1.97% | 17.13% | 78.33% | |
58 Neutral | ¥18.25B | 58.26 | ― | 2.65% | 0.81% | -26.76% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:7743
Seed Co., Ltd.
603.00
159.90
36.09%
JP:3046
JINS HOLDINGS
5,370.00
-1,988.66
-27.02%
JP:7780
Menicon Co
1,720.00
586.10
51.69%
JP:3360
Ship Healthcare Holdings
2,465.00
565.29
29.76%
JP:5889
Japan Eyewear Holdings Co.,Ltd.
2,113.00
177.41
9.17%
JP:7730
Mani, Inc.
1,533.00
488.00
46.70%
Seed Co., Ltd. Corporate Events
Seed Co. to Shift Listing From TSE Prime to Standard Market
Mar 24, 2026
Seed Co., Ltd. will move its stock listing from the Tokyo Stock Exchange Prime Market to the Standard Market, effective March 31, 2026, following approval from the exchange. As a result, the company has withdrawn its previously announced plan to m...
Seed Co. Posts Higher Nine-Month Profit and Confirms Full-Year Outlook
Feb 9, 2026
Seed Co., Ltd. reported consolidated net sales of ¥25.52 billion for the nine months ended December 31, 2025, up 1.3% year on year, with operating profit rising 2.2% to ¥1.29 billion and profit attributable to owners of parent increasing...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.